Fair value · TAPESTRY, INC. (TPR) · updated 2026-09-07 · from 10-K FY2026
Cboe · delayed 15 min · as of 03:42 ET
Are those assumptions reasonable? Use TPR’s filed growth history and the AI chat to decide, then set your own inputs below — the range you build is yours.
What the price implies
price ÷ trailing EPS
per year for 10 years, discounted at 10%
(market cap + net debt) ÷ EBITDA
free cash flow ÷ enterprise value (15.4× EV/FCF)
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from SEC filings. This price: Cboe · delayed 15 min · as of 03:42 ET.
With preset inputs the methods land at $93 – $156 (presets are filed history and our reference settings, not a recommendation)
Bear, base and bull are the 25th, 50th and 75th percentile of the methods that produced a usable estimate. Weights say how much a method is trusted for this sector; they do not change the range.
| Method | Estimate | vs price | Weight | Why this method |
|---|---|---|---|---|
Graham Number Medium weight Benjamin Graham’s 1949 rule of thumb: √(22.5 × EPS × book value). It punishes asset-light companies, so it reads low for big tech. | $24 | -81% | Medium weight | Benjamin Graham’s 1949 rule of thumb: √(22.5 × EPS × book value). It punishes asset-light companies, so it reads low for big tech. |
EV/EBITDA Medium weight Values the whole business at 10× EBITDA and divides by the share count. A mid-cycle industrial multiple; fast growers trade far above it. | $90 | -26% | Medium weight | Values the whole business at 10× EBITDA and divides by the share count. A mid-cycle industrial multiple; fast growers trade far above it. |
Earnings Power Value Medium weight Greenwald’s Earnings Power Value: what current earnings are worth if they never grow. Everything above it is what you pay for growth. Using normalized EBIT (3-year average) | $100 | -18% | Medium weight | Greenwald’s Earnings Power Value: what current earnings are worth if they never grow. Everything above it is what you pay for growth. |
P/E vs sector Medium weight Trailing diluted EPS times the sector median P/E. What the stock would be worth if the market priced it like an average peer. | $137 | +12% | Medium weight | Trailing diluted EPS times the sector median P/E. What the stock would be worth if the market priced it like an average peer. |
EV/FCF Medium weight 20× free cash flow per share, i.e. a 5% cash yield. Reads low for companies the market expects to keep growing. | $163 | +33% | Medium weight | 20× free cash flow per share, i.e. a 5% cash yield. Reads low for companies the market expects to keep growing. |
Growth-trajectory DCF Medium weight A two-stage DCF that grows earnings at the company’s own EPS trend, then fades to the industry’s long-run rate. Two-stage DCF using weighted EPS CAGR and industry median terminal rate | $194 | +59% | Medium weight | A two-stage DCF that grows earnings at the company’s own EPS trend, then fades to the industry’s long-run rate. |
DCF High weight Projects free cash flow for the coming years and discounts it back to today. The most complete method, and the most sensitive to the growth and discount-rate assumptions. estimate at or below $0, or more than 4× away from the price | Not meaningful for this company | High weight | Projects free cash flow for the coming years and discounts it back to today. The most complete method, and the most sensitive to the growth and discount-rate assumptions. | |
P/B vs sector Medium weight Sector median price-to-book times book value per share. Works for banks and asset-heavy businesses, says little about software. P/B comparable is optional for non-financial companies | No estimate | Medium weight | Sector median price-to-book times book value per share. Works for banks and asset-heavy businesses, says little about software. | |
10-K FY2026 · fiscal year ended 2026-06-27 · filed 2026-08-13 · accession 0001116132-26-000018
Trailing-twelve-month EPS also uses the quarterly 10-Qs through Q4 FY2026 (filed 2026-08-13).
Open this filing on sec.govEvery method that could be solved backwards opens on the assumption today’s price makes, so the top range sits on the price — that is arithmetic, not a view. Change any input and it becomes yours.
We don’t tell you what TPR is worth. Every tab OPENS on what today’s price implies for that method’s key assumption; you decide whether that assumption is reasonable — the growth matrix has TPR’s filed history and the AI chat will reason it through with you — and the range you build is yours. Our presets are filed history and reference settings, never a recommendation.
Discounted cash flow
$491.67per share
303% above the $122.14 price· outside the ±300% band, left out of the range
Your stage-1 FCF growth (60.0%) is above the -28.0% the price implies — your value lands 303% above the price.
Preset inputs — revenue-driven DCF from the latest filing
Implied by today’s price
At $122.14 the market implies a stage-1 FCF growth of -28.0%. (two-stage FCF model solved for stage-1 growth at 4.07% WACC)
The price implies stage-1 FCF growth of -28.0%, outside the range this slider covers. Showing preset inputs.
Implied discount rate (holding growth): 37.6% · the WACC that makes the same model print the price
That is the assumption the market is making — not ours, and not a recommendation. Decide whether it is reasonable: the growth matrix shows what TPR has actually filed, and the AI chat will reason it through with you.
Free cash flow grows at your stage-1 rate, then your stage-2 rate, then a terminal rate; everything is discounted at your WACC.
Yearly free-cash-flow growth for the first stage. Starts below zero so a shrinking-cash-flow case — and the rate today’s price implies — can be set.
How long stage-1 growth lasts.
Slower growth after stage 1, before the terminal phase.
Growth forever after the two stages. Above ~3% is rarely justified.
The return you require. Default is the WACC EvidInvest computed for this company. Higher discount rate, lower value.
| Year | Stage | FCF | Present value |
|---|---|---|---|
| 1 | Stage 1 | $2,901M | $2,787M |
| 2 | Stage 1 | $4,641M | $4,285M |
| 3 | Stage 1 | $7,426M | $6,588M |
| 4 | Stage 1 | $11,882M | $10,129M |
| 5 | Stage 1 | $19,011M | $15,573M |
| 6 | Stage 2 | $20,589M | $16,206M |
| 7 | Stage 2 | $22,297M | $16,865M |
| 8 | Stage 2 | $24,148M | $17,550M |
| 9 | Stage 2 | $26,152M | $18,263M |
| 10 | Stage 2 | $28,323M | $19,006M |
Inputs from the filing
10-K FY2026 · period ended 2026-06-27 · filed 2026-08-13 · accession 0001116132-26-000018 · sec.gov
Prefer a blank slate with reverse DCF? Open the standalone DCF / reverse DCF for TPR
Download the full TPR valuation report (PDF) — free
DCF fair value, Graham number, EPV, key multiples and growth rates in one clean PDF.
1.44
Put/Call (OI)
put-heavy
0.72
Put/Call (volume)
36%
ATM IV ~30d
$130
Call wall
2k OI
$22.5
Put wall
7k OI
As of previous close (2026-09-04) · OPRA historical data · walls = largest open-interest strikes above/below spot · market-wide positioning